Skip to main content
. 2019 Dec 27;98(52):e18414. doi: 10.1097/MD.0000000000018414

Figure 3.

Figure 3

Computed tomograhy presented the changes of lesions before and after Apatinib treatment. A/C: primary pulmonary inflammatory myofibroblastic tumor (IMT) (A) and intra-abdominal metastasis (C) before Apatinib treatment. B/D: primary pulmonary IMT (B) and intra-abdominal metastasis (D) after Apatinib treatment for 5 months.